These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 14702192

  • 1. Therapy-related changes of the bone marrow in chronic idiopathic myelofibrosis.
    Thiele J, Kvasnicka HM, Schmitt-Gräff A, Hülsemann R, Diehl V.
    Histol Histopathol; 2004 Jan; 19(1):239-50. PubMed ID: 14702192
    [Abstract] [Full Text] [Related]

  • 2. Bone marrow histopathology following cytoreductive therapy in chronic idiopathic myelofibrosis.
    Thiele J, Kvasnicka HM, Schmitt-Graeff A, Diehl V.
    Histopathology; 2003 Nov; 43(5):470-9. PubMed ID: 14636273
    [Abstract] [Full Text] [Related]

  • 3. Dynamics of fibrosis in chronic idiopathic (primary) myelofibrosis during therapy: a follow-up study on 309 patients.
    Thiele J, Kvasnicka HM, Schmitt-Graeff A, Diehl V.
    Leuk Lymphoma; 2003 Jun; 44(6):949-53. PubMed ID: 12854892
    [Abstract] [Full Text] [Related]

  • 4. Effects of chemotherapy (busulfan-hydroxyurea) and interferon-alfa on bone marrow morphologic features in chronic myelogenous leukemia. Histochemical and morphometric study on sequential trephine biopsy specimens with special emphasis on dynamic features.
    Thiele J, Kvasnicka HM, Schmitt-Graeff A, Bundschuh S, Biermann T, Roessler G, Wasmus M, Diehl V, Zankovich R, Schaefer HE.
    Am J Clin Pathol; 2000 Jul; 114(1):57-65. PubMed ID: 10884800
    [Abstract] [Full Text] [Related]

  • 5. Evolution of myelofibrosis in chronic idiopathic myelofibrosis as evidenced in sequential bone marrow biopsy specimens.
    Buhr T, Büsche G, Choritz H, Länger F, Kreipe H.
    Am J Clin Pathol; 2003 Jan; 119(1):152-8. PubMed ID: 12520711
    [Abstract] [Full Text] [Related]

  • 6. The impact of interferon versus busulfan therapy on the reticulin stain-measured fibrosis in CML--a comparative morphometric study on sequential trephine biopsies.
    Thiele J, Kvasnicka HM, Niederle N, Zirbes TK, Schmidt M, Dammasch J, Meuter BR, Leder LD, Kloke O, Diehl V.
    Ann Hematol; 1995 Mar; 70(3):121-8. PubMed ID: 7536475
    [Abstract] [Full Text] [Related]

  • 7. Therapy-related changes of CD34+ progenitor cells in chronic myeloid leukemia: a morphometric study on sequential trephine biopsies.
    Thiele J, Kvasnicka HM, Schmitt-Graeff A, Goekce D, Diehl V, Zankovich R, Schaefer HE.
    J Hematother Stem Cell Res; 2001 Dec; 10(6):827-36. PubMed ID: 11798509
    [Abstract] [Full Text] [Related]

  • 8. Relevance of bone marrow features in the differential diagnosis between essential thrombocythemia and early stage idiopathic myelofibrosis.
    Thiele J, Kvasnicka HM, Zankovich R, Diehl V.
    Haematologica; 2000 Nov; 85(11):1126-34. PubMed ID: 11064463
    [Abstract] [Full Text] [Related]

  • 9. Changing patterns of histological subgroups during therapy of Ph1+ chronic myelogenous leukaemia.
    Thiele J, Kvasnicka HM, Schmitt-Graeff A, Leder LD, Schaefer HE.
    Histopathology; 2000 Oct; 37(4):355-62. PubMed ID: 11012743
    [Abstract] [Full Text] [Related]

  • 10. [Successful treatment of primary myelofibrosis by busulfan pulse therapy: report of a case].
    Uemura Y, Iwahara Y, Kataoka R, Muneishi H, Miyoshi I.
    Rinsho Ketsueki; 1990 Sep; 31(9):1553-6. PubMed ID: 2246832
    [Abstract] [Full Text] [Related]

  • 11. Early-stage idiopathic (primary) myelofibrosis--current issues of diagnostic features.
    Thiele J, Kvasnicka HM, Zankovich R, Diehl V.
    Leuk Lymphoma; 2002 May; 43(5):1035-41. PubMed ID: 12148883
    [Abstract] [Full Text] [Related]

  • 12. Initial (prefibrotic) stages of idiopathic (primary) myelofibrosis (IMF) - a clinicopathological study.
    Thiele J, Kvasnicka HM, Boeltken B, Zankovich R, Diehl V, Fischer R.
    Leukemia; 1999 Nov; 13(11):1741-8. PubMed ID: 10557047
    [Abstract] [Full Text] [Related]

  • 13. Therapy-related changes of CD20+ and CD45RO+ lymphocyte subsets in chronic myeloid leukemia (CML): an immunohistochemical and morphometric study on sequential trephine biopsies of the bone marrow.
    Thiele J, Kvasnicka HM, Schmitt-Graeff A, Cvetanovska G, Blum N, Schaefer HE.
    Mod Pathol; 2000 Aug; 13(8):888-96. PubMed ID: 10955456
    [Abstract] [Full Text] [Related]

  • 14. Clinical and morphological criteria for the diagnosis of prefibrotic idiopathic (primary) myelofibrosis.
    Thiele J, Kvasnicka HM, Zankovich R, Diehl V.
    Ann Hematol; 2001 Mar; 80(3):160-5. PubMed ID: 11320901
    [Abstract] [Full Text] [Related]

  • 15. Clinicopathological impact of the interaction between megakaryocytes and myeloid stroma in chronic myeloproliferative disorders: a concise update.
    Thiele J, Kvasnicka HM, Fischer R, Diehl V.
    Leuk Lymphoma; 1997 Feb; 24(5-6):463-81. PubMed ID: 9086437
    [Abstract] [Full Text] [Related]

  • 16. Comparative effects of interferon and hydroxyurea on bone marrow fibrosis in chronic myelogenous leukemia.
    Thiele J, Kvasnicka HM.
    Leuk Lymphoma; 2001 Feb; 42(5):855-62. PubMed ID: 11697640
    [Abstract] [Full Text] [Related]

  • 17. Histochemistry and morphometry on bone marrow biopsies in chronic myeloproliferative disorders - aids to diagnosis and classification.
    Thiele J, Kvasnicka HM, Fischer R.
    Ann Hematol; 1999 Nov; 78(11):495-506. PubMed ID: 10602893
    [Abstract] [Full Text] [Related]

  • 18. Megakaryopoiesis and myelofibrosis in chronic myeloid leukemia after allogeneic bone marrow transplantation: an immunohistochemical study of 127 patients.
    Thiele J, Kvasnicka HM, Beelen DW, Flucke U, Spoer C, Paperno S, Leder LD, Schaefer UW.
    Mod Pathol; 2001 Feb; 14(2):129-38. PubMed ID: 11235904
    [Abstract] [Full Text] [Related]

  • 19. Effects of interferon and hydroxyurea on bone marrow fibrosis in chronic myelogenous leukaemia: a comparative retrospective multicentre histological and clinical study.
    Thiele J, Kvasnicka HM, Schmitt-Graeff A, Spohr M, Diehl V, Zankovich R, Niederle N, Leder LD.
    Br J Haematol; 2000 Jan; 108(1):64-71. PubMed ID: 10651725
    [Abstract] [Full Text] [Related]

  • 20. [Choice of therapy and overall survival in patients with chronic myeloproliferative diseases].
    Rukavitsyn OA, Pop VP, Seriakov AP.
    Vopr Onkol; 2004 Jan; 50(4):435-9. PubMed ID: 15605767
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.